Equities

Healius Ltd

Healius Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)1.31
  • Today's Change0.05 / 3.98%
  • Shares traded7.19m
  • 1 Year change-55.10%
  • Beta1.0994
Data delayed at least 20 minutes, as of May 21 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.

  • Revenue in AUD (TTM)1.69bn
  • Net income in AUD-984.10m
  • Incorporated1994
  • Employees10.50k
  • Location
    Healius LtdLevel 22Liberty Place, 161 Castlereagh StreetSYDNEY 2000AustraliaAUS
  • Phone+61 29432-9400
  • Fax+61 29432-9447
  • Websitehttps://www.healius.com.au/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Capitol Health Ltd229.29m6.14m266.51m--43.551.998.091.160.00570.00570.2140.12560.7237--47.34--1.973.052.273.5592.9492.412.734.24----0.5219130.9113.8111.90-203.87--19.924.56
Australian Unity Ltd2.00bn43.47m280.73m7.70k----2.890.1405--------0.2346----259,666.800.51050.5917--------2.182.65--2.250.6373--36.5012.7024.19---5.72--
Pacific Smiles Group Ltd173.72m6.61m304.00m800.0043.505.058.071.750.04380.04381.090.37740.92573.8857.63--3.523.614.444.5586.2585.003.803.680.56892.950.586278.8118.549.60153.43-18.18-4.27-15.55
Australian Clinical Labs Ltd674.03m15.43m468.25m5.12k30.262.823.320.69470.07670.07673.350.82211.146.779.12131,774.802.6515.433.9224.1582.7581.102.329.320.57352.890.664644.29-29.9912.95-79.86---4.29--
Monash IVF Group Ltd235.97m23.97m563.02m867.0023.652.0413.712.390.06110.06110.60140.70950.55723.8813.19272,169.605.675.666.746.3389.5289.4010.1711.020.28469.630.302468.4611.077.2318.650.451133.48-4.72
Integral Diagnostics Ltd456.31m-57.85m580.23m2.00k--1.93--1.27-0.2485-0.24851.941.290.575813.7121.44228,157.00-7.304.02-8.194.5595.2395.17-12.686.920.74152.040.546270.6422.1318.3671.4710.6830.60-5.01
Healius Ltd1.69bn-984.10m911.26m10.50k--0.8676--0.5386-1.45-1.432.531.450.47826.279.78161,123.80-27.810.6198-33.520.744187.0786.75-58.171.320.47131.070.606195.89-25.430.027-229.96---5.86--
Regis Healthcare Ltd950.89m-14.68m1.24bn9.00k--269.8511.101.30-0.0488-0.04883.160.01520.5274--45.73105,654.40-0.81450.0329-10.710.149-----1.540.07630.0716--0.94123,882.967.167.2726.67---25.03-11.97
Data as of May 21 2024. Currency figures normalised to Healius Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

54.79%Per cent of shares held by top holders
HolderShares% Held
Perpetual Investment Management Ltd.as of 06 May 2024105.18m14.49%
Australian Retirement Trust Pty Ltd.as of 20 Mar 202472.19m9.94%
Maple-Brown Abbott Ltd.as of 27 Dec 202334.98m4.82%
Dimensional Fund Advisors LPas of 31 Aug 202332.94m4.54%
The Vanguard Group, Inc.as of 31 Aug 202331.34m4.32%
First Sentier Investors (Australia) IM Ltd.as of 05 Feb 202430.56m4.21%
Colonial First State Investments Ltd.as of 25 Sep 202330.33m4.18%
State Street Global Advisors, Australia, Ltd.as of 03 Nov 202326.10m3.60%
Argo Investments Ltd. (Investment Management)as of 31 Aug 202320.67m2.85%
Wilson Asset Management (International) Pty Ltd.as of 30 Jun 202313.53m1.86%
More ▼
Data from 30 Jun 2023 - 17 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.